WLLW.TO stock is trading at C$0.035 on the TSX intraday session on 27 Feb 2026, driven by heavy volume and extreme gap below moving averages. The stock opened at C$0.03, hit a day high of C$0.035, and shows a relative volume of 26.31, signalling outsized trading activity. For short-term traders, this looks like a classic oversold bounce setup because the current price sits well beneath the 50-day average (C$0.14) and 200-day average (C$0.25). We use price action, volume, and valuation to frame a cautious bounce strategy.

Intraday snapshot for WLLW.TO stock

Price action is concentrated near the session top at C$0.035, with a day low of C$0.03 and volume at 3,804,082 shares. Average daily volume is 144,583, so trading runs nearly 26.31 times normal. Market cap sits at CAD 5,151,895.00, and shares outstanding are 147,196,992. One clear fact: intraday liquidity and volatility are elevated, increasing both short-term opportunity and execution risk.

Technical triggers and why this looks oversold

WLLW.TO stock trades far below its moving averages: 50-day C$0.14 and 200-day C$0.25, which flags an oversold equilibrium. The stock’s surge in relative volume with a narrow intraday range suggests short-covering or a concentrated buy interest. Traders should watch for a sustained move above C$0.04 to confirm early bounce strength.

Fundamentals and valuation for Willow Biosciences

Willow Biosciences (WLLW.TO) shows mixed fundamentals: EPS is -0.16 and price-to-book ratio is 0.03, indicating a low market valuation relative to reported book value C$1.13 per share. Price-to-sales is 0.96, and cash per share is C$1.15, supporting a high current ratio of 32.23. These metrics point to liquidity but also to operating losses and ongoing cash burn.

Meyka AI rates WLLW.TO with a score out of 100 and forecast

Meyka AI rates WLLW.TO with a score of 69.86 / 100 (Grade B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a near-term target of C$0.10, compared with the current price of C$0.035, implying an upside of 185.71%. Forecasts are model-based projections and not guarantees. Use this as scenario analysis, not advice.

Risks, catalysts, and sector context

Healthcare peers in Canada have been weak over the past year, with the sector down about 9.76% annually, adding pressure on small bioscience names. Key risks: continued negative EPS, low liquidity at tighter price points, and potential dilution from equity raises. Catalysts that could trigger a meaningful bounce include positive contract wins, commercial scale updates, or higher-than-expected revenue beats.

Trading strategy: oversold bounce playbook for WLLW.TO stock

For intraday and short swing traders, consider scaled entry near C$0.03–C$0.04 with a tight stop below C$0.025 to limit downside. Target partial exits at C$0.07 and C$0.10 if momentum holds. Keep position size small; implied volatility and spread risk are high. Confirm bounces with rising volume and a close above C$0.05 for conviction.

Final Thoughts

WLLW.TO stock trades at C$0.035 on the TSX intraday session on 27 Feb 2026 and meets technical criteria for an oversold bounce given the extreme gap below the 50-day (C$0.14) and 200-day (C$0.25) averages and unusually high volume of 3,804,082 shares. Meyka AI rates the stock 69.86 / 100 (Grade B, HOLD) and models a near-term mean-reversion target of C$0.10, implying +185.71% from today’s price. That projection is a model output, not a guarantee. Traders should weigh the high execution risk, potential for dilution, and weak sector backdrop before acting. Use small sizing, clear stops, and confirm any bounce with improving volume and price above C$0.05.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.